The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
SMOChem. dUTP Solution – Sodium Salt (100 mM)
Use instead of dTTP in PCR and RT-PCR protocols to...
kit virotype Influenza A RT-PCR (96 reactions)
Kit designed for the detection of Influenza A virus RNA.
PANAMutyper™ R EGFR
To screen EGFR+ patients and determine their response to various...
PNAClamp™ Mutation Detection Kit c-KIT
For the detection of mutations associated with glioblastoma and myeloproliferative...